Pfizer Ventures Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 6
Professionals
  • Investments
  • 167
  • Portfolio
  • 51
  • Exits
  • 83
Exits

Pfizer Ventures General Information

Description

Founded in 2004, Pfizer Ventures is the corporate venture capital arm of Pfizer Inc. based in New York, New York. The firm seeks to invest in emerging companies that are developing transformative medicines and technologies. The firm focuses on early-stage opportunities including start-ups and also spinouts.

Contact Information

Year Founded
2004
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Corporate Venture Capital
Primary Office
  • 235 East 42nd Street
  • New York, NY 10017
  • United States
+1 (212) 000-0000

Pfizer Ventures Investments (167)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
TRexBio 08-Mar-2022 Early Stage VC 0000 Drug Discovery Startup 000000 0000000 00.0
000000000 0000000 01-Mar-2022 00000 00000 0000 Biotechnology Generating Revenue 0000 00-000000 00.0
000000 00000000000 11-Feb-2022 00000 00000 0000 Drug Discovery Startup 00000000000 0'0000000 00.0
000000 00000000000 25-Jan-2022 00000 00000 0000 Drug Discovery Generating Revenue 00000000000 0'0000000 00.0
0000000 23-Dec-2021 00000 00000 00000 Drug Discovery Generating Revenue 00000 0000000 00.0
00000 000000000 17-Nov-2021 00000 00000 00000 Decision/Risk Analysis Generating Revenue
00000 000000000000 08-Nov-2021 0000 000.00 Drug Discovery Clinical Trials - Phase 1 0000 00-000000 00.0
000000 00000000000 13-Oct-2021 00000 00000 0000 Drug Delivery Generating Revenue 0000 00-000000 00.0
Anjarium Biosciences 16-Sep-2021 Later Stage VC 000.00 Drug Delivery Generating Revenue
eFFECTOR Therapeutics 26-Aug-2021 PIPE 0000 Drug Discovery Profitable 00000 0000000 00.0
You’re viewing 10 of 167 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pfizer Ventures Exits (83)

Company Name Exit Date Exit Type Exit Size
Cydan 31-Dec-2021 Out of Business
0000 01-Nov-2021 000000 0000000000 00000
00000 00000000 08-Oct-2021 000 00000
0-000 000000000000 15-Jul-2021 0000000000
00000000 01-Jul-2021 000000000 00000000
0000 000000000000 16-May-2021 000000000000000000 000.00
000000000 09-Apr-2021 000 00000
000000 00000000000 01-Apr-2021 000000000 00000000
Bolt Biotherapeutics 05-Feb-2021 IPO 00000
Epic Sciences 01-Feb-2021 Secondary Transaction - Private
You’re viewing 10 of 83 exits. Get the full list »

Pfizer Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Pfizer Ventures Team (11)

Name Title Deals Funds Boards Office
Denis Patrick Ph.D Managing Partner & Vice President, WRDM 0 0 New York, NY
Barbara Dalton Ph.D Vice President, WWBD & Senior Managing Partner 00 0 0 New York, NY
Christopher O'Donnell Ph.D Partner & Executive Director, WRDM 0 0 New York, NY
Michael Baran Ph.D Partner & Executive Director, WRDM 0 0 New York, NY
Rana Al-Hallaq Ph.D Partner & Senior Director, WWBD 0 0 New York, NY
You’re viewing 5 of 11 team members. Get the full list »

Pfizer Ventures Co-Investors (247)

Name With Exits Lead Partner Series Industry
Alexandria Venture Investments 12 0 00 Series chart Industry bar
AbbVie Ventures 0 0 Series chart Industry bar
Citadel (Hedge Fund) 0 0 0 Series chart Industry bar
RA Capital Management 0 0 Series chart Industry bar
HBM Healthcare Investments 0 0 0 Series chart Industry bar
You’re viewing 5 of 247 co-investors. Get the full list »